170 related articles for article (PubMed ID: 38795981)
1. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
Ghanem M; Archer G; Crestani B; Mailleux AA
Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981
[TBL] [Abstract][Full Text] [Related]
2. [Fibroblast growth factor (FGF) endocrines and pulmonary fibrogenesis].
Ghanem M; Mailleux A; Crestani B
Rev Mal Respir; 2023 Mar; 40(3):239-242. PubMed ID: 36828676
[TBL] [Abstract][Full Text] [Related]
3. The Saga of Endocrine FGFs.
Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
[TBL] [Abstract][Full Text] [Related]
4. Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy.
Itoh N; Ohta H; Konishi M
Front Endocrinol (Lausanne); 2015; 6():154. PubMed ID: 26483756
[TBL] [Abstract][Full Text] [Related]
5. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
[TBL] [Abstract][Full Text] [Related]
6. The FGF metabolic axis.
Li X
Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factors: new insights, new targets in the management of diabetes.
Kyrou I; Weickert MO; Gharanei S; Randeva HS; Tan BK
Minerva Endocrinol; 2017 Sep; 42(3):248-270. PubMed ID: 27412358
[TBL] [Abstract][Full Text] [Related]
8. The structural biology of the FGF19 subfamily.
Beenken A; Mohammadi M
Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
[TBL] [Abstract][Full Text] [Related]
9. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
[TBL] [Abstract][Full Text] [Related]
10. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
[TBL] [Abstract][Full Text] [Related]
11. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.
Itoh N
Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Growth Factor Family in the Progression of Prostate Cancer.
Teishima J; Hayashi T; Nagamatsu H; Shoji K; Shikuma H; Yamanaka R; Sekino Y; Goto K; Inoue S; Matsubara A
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30720727
[TBL] [Abstract][Full Text] [Related]
13. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases.
Jia MQ; Guan CX; Tao JH; Zhou Y
Oxid Med Cell Longev; 2022; 2022():5042762. PubMed ID: 35677107
[TBL] [Abstract][Full Text] [Related]
15. FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
Joannes A; Brayer S; Besnard V; Marchal-Sommé J; Jaillet M; Mordant P; Mal H; Borie R; Crestani B; Mailleux AA
Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(7):L615-29. PubMed ID: 26773067
[TBL] [Abstract][Full Text] [Related]
16. FGF19 Is Downregulated in Idiopathic Pulmonary Fibrosis and Inhibits Lung Fibrosis in Mice.
Justet A; Ghanem M; Boghanim T; Hachem M; Vasarmidi E; Jaillet M; Vadel A; Joannes A; Mordant P; Bonniaud P; Kolb M; Ling L; Cazes A; Mal H; Mailleux A; Crestani B
Am J Respir Cell Mol Biol; 2022 Aug; 67(2):173-187. PubMed ID: 35549849
[TBL] [Abstract][Full Text] [Related]
17. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
Wu X; Li Y
Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
[TBL] [Abstract][Full Text] [Related]
18. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.
Feng S; Dakhova O; Creighton CJ; Ittmann M
Cancer Res; 2013 Apr; 73(8):2551-62. PubMed ID: 23440425
[TBL] [Abstract][Full Text] [Related]
19. Blockade of Pan-Fibroblast Growth Factor Receptors Mediates Bidirectional Effects in Lung Fibrosis.
Morizumi S; Sato S; Koyama K; Okazaki H; Chen Y; Goto H; Kagawa K; Ogawa H; Nishimura H; Kawano H; Toyoda Y; Uehara H; Nishioka Y
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):317-326. PubMed ID: 32338990
[TBL] [Abstract][Full Text] [Related]
20. Endocrine fibroblast growth factors as regulators of metabolic homeostasis.
Kurosu H; Kuro-O M
Biofactors; 2009; 35(1):52-60. PubMed ID: 19319846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
